Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial
Martina Oneko, Laura C. Steinhardt, Reuben Yego, Ryan E. Wiegand, Phillip A. Swanson, Natasha KC, Dorcas Akach, Tony Sang, Julie Gutman, Elizabeth L. Nzuu, Allan Dungani, B. Kim Lee Sim, Paul Ndaya Oloo, Kephas Otieno, Dennis K Bii, Peter F. Billingsley, Eric R. James, Simon Kariuki, Aaron M. Samuels, Said Jongo, Winnie Chebore, Salim Abdulla, Claudia Daubenberger, Maxmillian Mpina, David Styers, Gail E. Potter, Ginnie Abarbanell, Thomas L. Richie, Stephen L. Hoffman, Robert A. Seder
Topics & Concepts
TolerabilityMedicineMalariaMalaria vaccineImmunogenicityPlaceboPlasmodium falciparumVaccinationVaccine efficacyAdverse effectImmunologyClinical endpointImmunityRandomized controlled trialInternal medicineImmune systemPathologyAlternative medicineMalaria Research and ControlMosquito-borne diseases and controlTravel-related health issues